Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis …
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis …
Diabetes is of primarily two types – Diabete mellitus (Type-I and Type II) and Diabetes insipidus. What is type-1 d…
Best Agrolife Ltd. Receives Patent for Novel Ternary Pesticide Formulation to Combat Major Paddy Pests and Diseases M…
“The Right of Persons with Disabilities bill- 2016” was passed by both houses Rajya Sabha and Lok Sabha. The Disabili…
Inviting applications for various post under Integrated Disease Surveillance Project (IDSP) State Health Society, …
“Recurrent headaches…sleepless nights…pale skin…lack of concentration….extra pounds…and yes the always there—HAI…
Public Health Initiatives by Takeda to Strengthen Health System for Rare Diseases in India Mumbai, May 17, …
USAID and Takeda Launch Dengue Prevention Campaign “ हारेगा डेंगू , हराएंगे हम ” campaign launched to spread awaren…
PREMIUM JOBS Programme Manager - Survivors’ Leadership Program Kamonohashi Project Location: Mumbai,Thane,Pune,Ma…